01 3Argamate
Calcium Polystyrene Sulphonate
Main Therapeutic Indication : Renal Disorders
Currency : USD
2018 Revenue in Millions : 49
2017 Revenue in Millions : 52
Growth (%) : -7%
Calcium polystyrene sulphonate
Main Therapeutic Indication : Hyperkalemia
Currency : USD
2016 Revenue in Millions : 53
2015 Revenue in Millions : 55
Growth (%) : -3
Calcium Polystyrene Sulphonate
Main Therapeutic Indication : Hyperkalemia
Currency : USD
2017 Revenue in Millions : 56
2016 Revenue in Millions : 57
Growth (%) : -2
LOOKING FOR A SUPPLIER?